by Mike Campbell
September
27, 2022
from
TheCounterSignal Website
Genetically modified mosquitoes
vaccinate a human
The
total takeover of all genetic material on earth will
spawn projects like this, to use weaponize nature
against humans to control human health.
This
will fit well with Biden's new Executive Order, National
Biotechnology and Biomanufacturing Initiative, that
institutionalizes research and development of genetic
modification across all branches of government and with
billions in grants.
Source
A box full of genetically modified mosquitoes successfully
vaccinated a human against malaria in a trial funded by the
National Institute of Health (NIH).
The study involved about 200 hungry mosquitoes biting a human
subject's arm.
Human participants placed
their arms directly over a small box full of the bloodsuckers.
"We use the
mosquitoes like they're 1,000 small flying syringes," said
researcher Dr. Sean Murphy, as reported by NPR.
Three to five
"vaccinations" took place over 30-day intervals.
The mosquitoes gave minor versions of malaria that didn't make
people sick, but gave them antibodies.
Efficacy from the
antibodies lasted a few months.
"Half of the
individuals in each vaccine group did not develop detectable P.
falciparum infection, and a subset of these individuals was
subjected to a second CHMI 6 months later and remained partially
protected.
These results support
further development of genetically attenuated sporozoites as
potential malaria vaccines," researchers concluded.
Carolina Reid was
one of twenty-six participants in the study.
"My whole forearm
swelled and blistered. My family was laughing, asking like, 'why
are you subjecting yourself to this?'"
Reid enjoyed her
experience so much that she says she wants to participate in as many
vaccine trials as she can.
For this research, each
participant received $4,100 as an incentive. Adverse reactions were
what one would expect after getting bit by hundreds of mosquitoes
and nothing more.
Dr. Kirsten Lyke calls the research "a total game changer."
Lyke led the phase 1
trials for
Pfizer's COVID-19 vaccine and
was a co-investigator for Moderna and Novavax
COVID vaccines...
Researchers say the
genetically modified mosquitoes will not be used at large to
vaccinate millions of people.
The reason why mosquitoes
were used instead of syringes, they claim, was to save costs.
"He and his
colleagues went this route because it is costly and time
consuming to develop a formulation of a parasite that can be
delivered with a needle," NPR reports.
|